NCT00976534 - Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Study Completion Date

February 28, 2010

Conditions

PainNeuropathic Pain

Interventions

DRUG

AZD1386

90 mg, capsules, oral, during 3 weeks

DRUG

Placebo

capsules, oral, during 3 weeks

Trial Locations (12)

Research Site, Calgary

Research Site, Halifax

Research Site, Toronto

Research Site, Aalborg

Research Site, Arhus C

Research Site, Boulogne-Billancourt

Research Site, Clermont-Ferrand

Research Site, Nice

Research Site, Bradford

Research Site, Glasgow

Research Site, London

Research Site, Manchester